Manufactures and supplies bromine compounds for pharmaceuticals and speciality chemicals.
Annual revenue $770,510 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors - Brand Intelligence

About Deep Pharm

Deep Pharm is a company based in India. It operates as a B2B. Deep Pharm offers products and services including 2-Bromopropionic Acid, 3-Bromopropionic Acid, Hydrobromic Acid 48%, Hydrobromic Acid 55%, and Hydrobromic Acid 62%.

  • Headquarter India
  • Sectors
    Chemicals & Materials
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Deep Pharm-Chem Private Limited
  • Date of Incorporation 07 Jun, 1991
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Chemicals & Materials → Pulp, Paper & Packaging Materials Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $770.51 K (USD)
    -16.4
    as on Mar 31, 2023
  • Net Profit
    $30.5 K (USD)
    -42.4
    as on Mar 31, 2023
  • EBITDA
    $52.45 K (USD)
    -51.74
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Deep Pharm

Deep Pharm offers a comprehensive portfolio of products and services, including 2-Bromopropionic Acid, 3-Bromopropionic Acid, Hydrobromic Acid 48%, Hydrobromic Acid 55%, and Hydrobromic Acid 62%.

Product name locked
Category locked
Primary

Bromine-based acid used in pharmaceutical and chemical synthesis

Product name locked
Category locked
Locked

Organic bromine compound for speciality chemical applications

Product name locked
Category locked
Locked

Acid solution for industrial and pharmaceutical processes

Product name locked
Category locked
Locked

Concentrated acid for chemical manufacturing uses

Product name locked
Category locked
Locked

High-strength acid for speciality chemical production

Funding Insights of Deep Pharm

Premium access

Detailed funding history for Deep Pharm

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Deep Pharm

Investments
Premium access

Investment portfolio details for Deep Pharm

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Deep Pharm

Premium access

Detailed financials for Deep Pharm

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Deep Pharm Comparisons

Deep Pharm Primary company
Description
Manufactures and supplies bromine compounds for pharmaceutic...
Location
India
Founded Year
-
Annual Revenue
$770.51 K (USD)
Net Profit
$30.5 K (USD)
EBITDA
$52.45 K (USD)
Employees
Not available
Premium access

Peer comparison for Deep Pharm

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Deep Pharm

Premium access

Detailed competitors of Deep Pharm

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Deep Pharm

Premium access

Complete news archive for Deep Pharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deep Pharm

Deep Pharm is headquartered in India.

Annual revenue of Deep Pharm is $770.51K as on Mar 31, 2023.

Deep Pharm-Chem Pvt. Ltd., established in 1991, is a manufacturer and supplier of organic and inorganic bromine compounds, including 2-Bromopropionic Acid and various strengths of Hydrobromic Acid. Operating from Ankleshwar, Gujarat, with an office in Mumbai, India, the company focuses on producing high-quality chemicals for pharmaceuticals, fine chemicals, and industrial applications. They serve businesses in the chemical sector through direct manufacturing and distribution processes.

Deep Pharm offers 2-Bromopropionic Acid, 3-Bromopropionic Acid, Hydrobromic Acid 48%, Hydrobromic Acid 55%, and Hydrobromic Acid 62%.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available